Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiuzhen Wang, Qing Zhang, Lingyan Lv, Junjie Fu, Yan Jiang, Hongliang Xin & Qizheng Yao. (2017) Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy. Drug Delivery 24:1, pages 1401-1409.
Read now
Read now
Articles from other publishers (27)
Cinzia Cocola, Valerio Magnaghi, Edoardo Abeni, Paride Pelucchi, Valentina Martino, Laura Vilardo, Eleonora Piscitelli, Arianna Consiglio, Giorgio Grillo, Ettore Mosca, Roberta Gualtierotti, Daniela Mazzaccaro, Gina La Sala, Chiara Di Pietro, Mira Palizban, Sabino Liuni, Giuseppina DePedro, Stefano Morara, Giovanni Nano, James Kehler, Burkhard Greve, Alessio Noghero, Daniela Marazziti, Federico Bussolino, Gianfranco Bellipanni, Igea D’Agnano, Martin Götte, Ileana Zucchi & Rolland Reinbold. (2021) Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Daliang Liu, Guang Cheng, Xiaowei Ma, Shuailiang Wang, Xiaohu Zhao, Wei Zhang, Weidong Yang & Jing Wang. (2021)
PET/CT using
68
Ga‐PSMA‐617 versus
18
F‐fluorodeoxyglucose to differentiate low‐ and high‐grade gliomas
. Journal of Neuroimaging 31:4, pages 733-742.
Crossref
Crossref
Anne Blank, Irina Kremenetskaia, Ruth M Urbantat, Güliz Acker, Kati Turkowski, Josefine Radke, Ulf C Schneider, Peter Vajkoczy & Susan Brandenburg. (2020) Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma. The Journal of Pathology 253:2, pages 160-173.
Crossref
Crossref
Susan Brandenburg, Anne Blank, Alexander D. Bungert & Peter Vajkoczy. (2020) Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?. International Journal of Molecular Sciences 22:1, pages 194.
Crossref
Crossref
Yan Li, Linying Liu, Weihong Ji, Huang Peng, Ruichen Zhao & Xin Zhang. (2020) Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy. Nano Today 35, pages 101006.
Crossref
Crossref
V. M. Chertok, N. V. Zakharchuk & A. G. Chertok. (2019) Cellular-Molecular Mechanisms of the Regulation of Angiogenesis in the Brain. Neuroscience and Behavioral Physiology 49:5, pages 544-554.
Crossref
Crossref
Arsela Prelaj, Sara Elena Rebuzzi, Maurizio Salvati, Silvia Pecorari, Chiara Pozzi, Carmela Fusto, Carla Ferrara, Silverio Tomao & Vincenzo Bianco. (2018) Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomas. Translational Medicine Communications 3:1.
Crossref
Crossref
Amrita Kadari, Deep Pooja, Ravuri Halley Gora, Sagarika Gudem, Venkata Ramana Murthy Kolapalli, Hitesh Kulhari & Ramakrishna Sistla. (2018) Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. European Journal of Pharmaceutics and Biopharmaceutics 132, pages 168-179.
Crossref
Crossref
Xianquan Zhan & Na Li. 2018. Electrophoresis - Life Sciences Practical Applications. Electrophoresis - Life Sciences Practical Applications.
Zhiguo Lu, Yan Li, Yuanjie Shi, Yanhui Li, Zuobing Xiao & Xin Zhang. (2017) Traceable Nanoparticles with Spatiotemporally Controlled Release Ability for Synergistic Glioblastoma Multiforme Treatment. Advanced Functional Materials 27:46, pages 1703967.
Crossref
Crossref
V. M. Chertok, N. V. Zakharchuk & A. G. Chertok. (2017) The cellular and molecular mechanisms of angiogenesis regulation in the brain. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:8, pages 43.
Crossref
Crossref
J.T. Jo & D. Schiff. 2017. Critical Care Neurology Part II. Critical Care Neurology Part II
715
741
.
Anne Hertenstein, Thomas Hielscher, Oliver Menn, Benedikt Wiestler, Frank Winkler, Michael Platten, Wolfgang Wick & Antje Wick. (2016) Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma. Journal of Neuro-Oncology 129:3, pages 533-539.
Crossref
Crossref
Fang Peng, Jianglin Li, Tianyao Guo, Haiyan Yang, Maoyu Li, Shushan Sang, Xuejun Li, Dominic M. Desiderio & Xianquan Zhan. (2015) Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry. Journal of the American Society for Mass Spectrometry 26:12, pages 2062-2076.
Crossref
Crossref
Cheng-Xiang Zhang, Wei-Yu Zhao, Lei Liu, Rui-Jun Ju, Li-Min Mu, Yao Zhao, Fan Zeng, Hong-Jun Xie, Yan Yan & Wan-Liang Lu. (2015) A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Oncotarget 6:32, pages 32681-32700.
Crossref
Crossref
Clara Chen, Arliene Ravelo, Elaine Yu, Rahul Dhanda & Ian Schnadig. (2015) Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices. Journal of Neuro-Oncology 122:3, pages 595-605.
Crossref
Crossref
Natsuko Nomura, Sandra Pastorino, Pengfei Jiang, Gage Lambert, John R Crawford, Marco Gymnopoulos, David Piccioni, Tiffany Juarez, Sandeep C Pingle, Milan Makale & Santosh Kesari. (2014) Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell International 14:1.
Crossref
Crossref
Irene TsiapaGeorge LoudosEirini A. FragogeorgiPenelope BouziotisDimitrios PsimadasStavros XanthopoulosMaria Paravatou-PetsotasLazaros PalamarisAlexandra D. VarvarigouDimitris KarnabatidisGeorge C. Kagadis. (2014)
Evaluation of α
ν
β
3
-Mediated Tumor Expression with a
99m
Tc-Labeled Ornithine-Modified RGD Derivative During Glioblastoma Growth
In Vivo
. Cancer Biotherapy and Radiopharmaceuticals 29:10, pages 444-450.
Crossref
Crossref
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref
Crossref
YASUTO AKIYAMA, MASARU KOMIYAMA, HARUO MIYATA, MIKA YAGOTO, TADASHI ASHIZAWA, AKIRA IIZUKA, CHIE OSHITA, AKIKO KUME, MASAHIRO NOGAMI, ICHIRO ITO, REIKO WATANABE, TAKASHI SUGINO, KOICHI MITSUYA, NAKAMASA HAYASHI, YOKO NAKASU & KEN YAMAGUCHI. (2014) Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients. Oncology Reports 31:4, pages 1683-1690.
Crossref
Crossref
Huile Gao, Yang Xiong, Shuang Zhang, Zhi Yang, Shijie Cao & Xinguo Jiang. (2014) RGD and Interleukin-13 Peptide Functionalized Nanoparticles for Enhanced Glioblastoma Cells and Neovasculature Dual Targeting Delivery and Elevated Tumor Penetration. Molecular Pharmaceutics 11:3, pages 1042-1052.
Crossref
Crossref
Huile Gao, Zhi Yang, Shijie Cao, Yang Xiong, Shuang Zhang, Zhiqing Pang & Xinguo Jiang. (2014) Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials 35:7, pages 2374-2382.
Crossref
Crossref
Monserrat Llaguno-Munive, Luis Alberto Medina, Rafael Jurado, Mario Romero-Piña & Patricia Garcia-Lopez. (2013) Mifepristone improves chemo-radiation response in glioblastoma xenografts. Cancer Cell International 13:1.
Crossref
Crossref
A. Beheshti, B. R. Pinzer, J. T. McDonald, M. Stampanoni & L. Hlatky. (2013) Early Tumor Development Captured Through Nondestructive, High Resolution Differential Phase Contrast X-ray Imaging. Radiation Research 180:5, pages 448-454.
Crossref
Crossref
J.A. Coulter, W.B. Hyland, J. Nicol & F.J. Currell. (2013) Radiosensitising Nanoparticles as Novel Cancer Therapeutics — Pipe Dream or Realistic Prospect?. Clinical Oncology 25:10, pages 593-603.
Crossref
Crossref
Emerson Lim & Edward P. Gelmann. (2013) Renal Cell Cancer Treated with a Single-Edged Sword. Cell Reports 3:2, pages 275-276.
Crossref
Crossref
Yasuto Akiyama, Chie Oshita, Akiko Kume, Akira Iizuka, Haruo Miyata, Masaru Komiyama, Tadashi Ashizawa, Mika Yagoto, Yoshiaki Abe, Koichi Mitsuya, Reiko Watanabe, Takashi Sugino, Ken Yamaguchi & Yoko Nakasu. (2012) α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. BMC Cancer 12:1.
Crossref
Crossref